Int J Chron Obstruct Pulmon Dis. 2026 Nov 17;21:654828. doi: 10.2147/COPD.S654828. eCollection 2026.
ABSTRACT
Cardiopulmonary exercise testing (CPET) provides integrated physiological assessment in chronic obstructive pulmonary disease (COPD) and can inform exercise prescription, exertional evaluation, and specialist referral. This critical narrative review examines whether CPET information improves pulmonary rehabilitation (PR) treatment allocation and patient outcomes beyond comprehensive conventional assessment. Targeted PubMed/MEDLINE and ClinicalTrials.gov searches through September 5, 2026 were supplemented by focused revision checks; evidence directness was assessed at the claim level. Physiological measurement and clinically appropriate dose anchoring, diagnostic evaluation, and integrated care retain their established or context-specific rationales. The targeted searches did not identify a randomized COPD information-strategy or test-plus-treatment trial isolating additional PR allocation benefit; this does not establish absence of clinical value. We adapt test-utility methodology into an author-proposed, unvalidated research framework separating interpretation, recorded decisions, delivered actions, and measured outcomes. Four candidate questions identify settings for comparative investigation. Concordant conventional assessment is a comparison scenario, not a validated low-yield boundary or a rule to withhold CPET. An unchanged prescription may provide confirmation or reassurance; a changed prescription without detected benefit requires assessment of delivery, outcome sensitivity, follow-up, and statistical uncertainty. Prospective work should establish operational reproducibility and then compare complete strategies with domain-specific patient outcomes, safety, burden, and access. Clinically appropriate CPET remains part of individualized care, and lack of CPET should not delay indicated PR when assessment supports safe supervised participation. The framework organizes evaluation rather than selecting patients or prescribing treatment.
PMID:43068172 | PMC:PMC13788833 | DOI:10.2147/COPD.S654828